Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle-functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy

被引:63
作者
Kong, Feng [1 ,7 ]
Zhang, Hongbo [1 ,2 ,3 ]
Qu, Xiangmeng [1 ,2 ,4 ]
Zhang, Xu [2 ,5 ]
Chen, Dong [2 ]
Ding, Ruihua [2 ]
Makila, Ermei [6 ]
Salonen, Jarno [6 ]
Santos, Helder A. [3 ]
Hai, Mingtan [1 ,2 ]
机构
[1] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing Key Lab Funct Mat Mol & Struct Construct, Beijing 100083, Peoples R China
[2] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA
[3] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, FI-00014 Helsinki, Finland
[4] East China Normal Univ, Sch Chem & Mol Engn, 500 Dongchuan Rd, Shanghai 200241, Peoples R China
[5] Cape Breton Univ, 1250 Grand Lake Rd, Sydney, NS B1P 6L2, Canada
[6] Univ Turku, Dept Phys, Lab Ind Phys, FI-20014 Turku, Finland
[7] GRIKIN Adv Mat Co Ltd, 33 Chaoqian Rd, Beijing 102200, Peoples R China
基金
加拿大健康研究院; 欧洲研究理事会; 芬兰科学院;
关键词
WATER-SOLUBLE DRUGS; TRIGGERED RELEASE; ANTICANCER DRUGS; CANCER-THERAPY; ORAL DELIVERY; CO-DELIVERY; RESISTANCE; ENCAPSULATION; FABRICATION; CARRIER;
D O I
10.1002/adma.201602763
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Gold nanorods, DNA origami, and porous silicon nanoparticle-functionalized biocompatible double emulsion are developed for versatile molecular targeted therapeutics and antibody combination therapy. This advanced photothermal responsive all-in-one biocompatible platform can be easily formed with great therapeutics loading capacity for different cancer treatments with synergism and multidrug resistance inhibition, which has great potential in advancing biomedical applications.
引用
收藏
页码:10195 / 10203
页数:9
相关论文
共 47 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   Residual solvent testing: A review of gas-chromatographic and alternative techniques [J].
B'Hymer, C .
PHARMACEUTICAL RESEARCH, 2003, 20 (03) :337-344
[3]   Label-Free Biosensing with Lipid-Functionalized Gold Nanorods [J].
Castellana, Edward T. ;
Gamez, Roberto C. ;
Russell, David H. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (12) :4182-4185
[4]   Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer Therapy [J].
Chang, Microsugar ;
Yang, Chung-Shi ;
Huang, Dong-Ming .
ACS NANO, 2011, 5 (08) :6156-6163
[5]   pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: A comparative study with micelles [J].
Chen, Wei ;
Meng, Fenghua ;
Cheng, Ru ;
Zhong, Zhiyuan .
JOURNAL OF CONTROLLED RELEASE, 2010, 142 (01) :40-46
[6]  
Control H. J., 2006, J AM CHEM SOC, V128, P12205
[7]  
GRECO WR, 1995, PHARMACOL REV, V47, P331
[8]   Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia Model [J].
Halley, Patrick D. ;
Lucas, Christopher R. ;
McWilliams, Emily M. ;
Webber, Matthew J. ;
Patton, Randy A. ;
Kural, Comert. ;
Lucas, David M. ;
Byrd, John C. ;
Castro, Carlos E. .
SMALL, 2016, 12 (03) :308-320
[9]   On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications [J].
Herranz-Blanco, Barbara ;
Liu, Dongfei ;
Makila, Ermei ;
Shahbazi, Mohammad-Ali ;
Ginestar, Eloy ;
Zhang, Hongbo ;
Aseyev, Vladimir ;
Balasubramanian, Vimalkumar ;
Salonen, Jarno ;
Hirvonen, Jouni ;
Santos, Helder A. .
ADVANCED FUNCTIONAL MATERIALS, 2015, 25 (10) :1488-1497
[10]   Nanoparticle-assisted combination therapies for effective cancer treatment [J].
Hu, Che-Ming Jack ;
Aryal, Santosh ;
Zhang, Liangfang .
THERAPEUTIC DELIVERY, 2010, 1 (02) :323-334